[Alcohol withdrawal syndrome. Effects of short-term treatment with dapiprazole].
A study on dapiprazole, a new psychotropic agent, in the treatment of patients during the alcohol withdrawal syndrome, is reported. On the basis of evaluations made on the severity of the physical and psychic symptoms of withdrawal, the conclusion is drawn that the new psychotropic agent, administered at gradually increasing doses of 40 to 90 mg/kg for 7 days, completely controls the clinical symptomatology at least in 70% of the cases treated.
Bono
G
G
Università di Pavia, Istituto Neurologico C. Mondino, Clinica Malattie Nervose e Mentali.
Verri
A P
AP
Merlo
P
P
Mancuso
A
A
Sinforiani
E
E
Mazzella
G L
GL
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D004341:Drug Evaluation; D004361:Drug Tolerance; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D013997:Time Factors; D014230:Triazoles / Q000008:administration & dosage*
D014150:Antipsychotic Agents; D010879:Piperazines; D014230:Triazoles; D000431:Ethanol; C035289:dapiprazole
Sindrome da astineza alcoolica. Effetti del trattamento "short-term" con dapiprazolo.